Paul J. Kurtin

17.7k citations

235 papers · 11.4k indexed · 2 hit papers · h-index 64

Pathology and Forensic Medicine top 0.05%
Oncology top 0.5%
Molecular Biology top 2%
Genetics top 0.1%
Immunology top 1%

Co-authors: Ellen D. Remstein Geraldine S. Pinkus Jörg J. Goronzy Curtis A. Hanson Thomas M. Habermann Cornelia M. Weyand Thomas E. Witzig Angela Dispenzieri
Topics: Lymphoma Diagnosis and Treatment (123 papers)Chronic Lymphocytic Leukemia Research (66 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (57 papers)
Cited by: Pathology and Forensic Medicine Genetics Hematology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Journal of Experimental Medicine
Partner nations: United States Canada France

In The Last Decade

Paul J. Kurtin

230 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

2007 580 citations Ellen D. Remstein, Angela Dispenzieri et al. profile →
Lymphoid Neogenesis in Rheumatoid Synovitis

2001 537 citations Seisuke Takemura, Andrea Braun et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Paul J. Kurtin

Since Specialization

Citations

This map shows the geographic impact of Paul J. Kurtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Kurtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Kurtin more than expected).

Fields of papers citing papers by Paul J. Kurtin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Kurtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Kurtin. The network helps show where Paul J. Kurtin may publish in the future.

Co-authorship network of co-authors of Paul J. Kurtin

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Kurtin. A scholar is included among the top collaborators of Paul J. Kurtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Kurtin. Paul J. Kurtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gastrointestinal amyloidosis: an often unexpected finding with systemic implications 2023 ·Human Pathology ·Catherine E. Hagen,Surendra Dasari,Jason D. Theis,Karen L. Rech,Linda N. Dao,Matthew T. Howard,Angela Dispenzieri,April Chiu,(unknown),Paul J. Kurtin,Morie A. Gertz,Taxiarchis Kourelis,Eli Muchtar,Julie A. Vrana,Ellen D. McPhail	6
2	Aberrant expression of lymphoid enhancer–binding factor 1 in Hodgkin lymphoma 2022 ·Human Pathology ·Aishwarya Ravindran,Paul J. Kurtin,Rebecca L. King,Yuan Ji,Andrew L. Feldman,Karen L. Rech,Ellen D. McPhail,Sameer A. Parikh,Wei Ding,Min Shi	2
3	Association between spinal stenosis and wild-type ATTR amyloidosis 2021 ·Amyloid ·Amandeep Godara,Ron I. Riesenburger,(unknown),Cindy Varga,(unknown),Nauman Siddiqui,(unknown),Andy Wang,(unknown),(unknown),(unknown),Ellen D. McPhail,Paul J. Kurtin,Jason D. Theis,(unknown),Knarik Arkun,Monika Pilichowska,James Kryzanski,Ayan R. Patel,Raymond L. Comenzo	25
4	High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease? 2020 ·Blood Cancer Journal ·Priyanka A. Pophali,(unknown),Rhett P. Ketterling,Reid G. Meyer,Ellen D. McPhail,Paul J. Kurtin,Raphael Mwangi,Matthew J. Maurer,Thomas M. Habermann,Rebecca L. King	15
5	Non-Cardiac Biopsy Sites with High Frequency of Transthyretin Amyloidosis 2020 ·ESC Heart Failure ·Surendra Dasari,Angela Dispenzieri,(unknown),Prasuna Muppa,Paul J. Kurtin,Jason D. Theis,Julie A. Vrana,Martha Grogan,Taxiarchis Kourelis,Morie A. Gertz,Ellen D. McPhail	5
6	First Report of Bilateral External Auditory Canal Cochlin Aggregates (“Cochlinomas”) with Multifocal Amyloid-Like Deposits, Associated with Sensorineural Hearing Loss and a Novel Genetic Variant in COCH Encoding Cochlin 2019 ·Head and Neck Pathology ·(unknown),Nicole J. Boczek,Nahid G. Robertson,Samih H. Nasr,Daniel Jethanamest,Ellen D. McPhail,Paul J. Kurtin,Surendra Dasari,Malinda L. Butz,Cynthia C. Morton,W. Edward Highsmith,Fang Zhou	2
7	The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry 2019 ·Kidney International ·Maria Lourdes Gonzalez Suarez,Pingchuan Zhang,Samih H. Nasr,Insara Jaffer Sathick,Wonngarm Kittanamongkolchai,Paul J. Kurtin,Mariam P. Alexander,Lynn D. Cornell,Mary E. Fidler,Joseph P. Grande,Loren P. Herrera Hernandez,Samar M. Said,Sanjeev Sethi,Angela Dispenzieri,Morie A. Gertz,Nelson Leung	40
8	DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN 2017 ·Journal of the American Society of Nephrology ·Surendra Dasari,Mariam P. Alexander,Julie A. Vrana,Jason D. Theis,John R. Mills,Vivian Negron,Sanjeev Sethi,Angela Dispenzieri,W. Edward Highsmith,Samih H. Nasr,Paul J. Kurtin	71
9	Axillary Intraneural Ganglion Cysts. 2017 ·Journal of Surgical Orthopaedic Advances ·Kartik Krishnan,(unknown),Kimberly K. Amrami,Paul J. Kurtin,Robert J. Spinner	3
10	Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry 2016 ·Blood ·Taxiarchis Kourelis,Surendra Dasari,Jason D. Theis,Marina Ramı́rez-Alvarado,Paul J. Kurtin,Morie A. Gertz,Steven R. Zeldenrust,Roman M. Zenka,Ahmet Doǧan,Angela Dispenzieri	106
11	Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics 2014 ·Haematologica ·Julie A. Vrana,Jason D. Theis,Surendra Dasari,Oana Madalina Mereuta,Angela Dispenzieri,Steven R. Zeldenrust,MA Gertz,Paul J. Kurtin,Karen L. Grogg,Ahmet Doǧan	135
12	Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course 2008 ·Journal of Clinical Oncology ·(unknown),Brian Patrick O’Neill,Mark E. Law,Paul A. Decker,David M. Kurtz,Caterina Giannini,Alyx B. Porter,Paul J. Kurtin,Patrick B. Johnston,Ahmet Doǧan,Ellen D. Remstein	78
13	Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas 2008 ·Leukemia ·Andrew L. Feldman,(unknown),Mark E. Law,Anne J. Novak,Ayoma D. Attygalle,Erik C. Thorland,Stephanie Fink,Julie A. Vrana,Bolette L. Caron,William G. Morice,Ellen D. Remstein,Karen L. Grogg,Paul J. Kurtin,William R. Macon,Ahmet Doǧan	107
14	Primary Anaplastic Large Cell Lymphoma of the Central Nervous System 2003 ·The American Journal of Surgical Pathology ·David H. George,Bernd W. Scheithauer,Fügen Aker,Paul J. Kurtin,Peter C. Burger,José Cameselle‐Teijeiro,Roger E. McLendon,Joseph E. Parisi,Werner Paulus,Wolfgang Roggendorf,(unknown)	64
15	A New Method to Extract Nuclei from Paraffin-Embedded Tissue to Study Lymphomas Using Interphase Fluorescence in Situ Hybridization 2002 ·American Journal Of Pathology ·Sarah F. Paternoster,Stephanie R. Brockman,Rebecca F. McClure,Ellen D. Remstein,Paul J. Kurtin,Gordon W. Dewald	78
16	Trapping of Misdirected Dendritic Cells in the Granulomatous Lesions of Giant Cell Arteritis 2002 ·American Journal Of Pathology ·(unknown),(unknown),Myung-Shin Jeon,Paul J. Kurtin,Brian R. Younge,Jörg J. Goronzy,Cornelia M. Weyand	109
17	Hepatosplenic ɑß T-Cell Lymphomas 2001 ·The American Journal of Surgical Pathology ·William R. Macon,Nicolas Lévy,Paul J. Kurtin,Kevin E. Salhany,(unknown),Terence T. Casey,Fiona E. Craig,Cindy L. Vnencak‐Jones,Margaret L. Gulley,Jonathan P. Park,John B. Cousar	133
18	Lymphoid Neogenesis in Rheumatoid Synovitisbreakdown → 2001 ·The Journal of Immunology ·Seisuke Takemura,Andrea Braun,Cynthia S. Crowson,Paul J. Kurtin,Robert H. Cofield,W. Michael O’Fallon,Jörg J. Goronzy,Cornelia M. Weyand	537
19	Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells 1997 ·British Journal of Haematology ·Ayalew Tefferi,Curtis A. Hanson,Paul J. Kurtin,Jerry A. Katzmann,Robert J. Dalton,William L. Nichols	39
20	S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma 1995 ·Cancer ·Thomas E. Witzig,Thomas M. Habermann,Paul J. Kurtin,Georgene Schroeder,Mary Stenson,Philip R. Greipp	6

About Paul J. Kurtin

Paul J. Kurtin is a scholar working on Genetics, Pathology and Forensic Medicine and Nephrology, having authored 235 papers that have together received 11.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (123 papers), Chronic Lymphocytic Leukemia Research (66 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (57 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.1k citations), Genetics (2.8k citations) and Hematology (1.5k citations). Paul J. Kurtin has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Ellen D. Remstein, Geraldine S. Pinkus, Jörg J. Goronzy, Curtis A. Hanson, Thomas M. Habermann, Cornelia M. Weyand, Thomas E. Witzig, Angela Dispenzieri, Ahmet Doǧan and David J. Inwards. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact